330
Views
38
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Body mass index and outcomes in patients receiving chemotherapy for intermediate-grade B-cell non-Hodgkin lymphoma

, , &
Pages 1649-1657 | Received 01 Jan 2010, Accepted 15 May 2010, Published online: 31 Aug 2010

References

  • Ogden CL, Carroll MD, Curtin LR, et al Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295:1549–1555.
  • Fisher SG, Fisher RI. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004;23:6524–6534.
  • Renehan AG, Tyson M, Egger M, et al Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569–578.
  • Bastarrachea J, Hortobagyi GN, Smith TL, et al Obesity as an adverse prognostic factor for patients receiving adjuvant chemotherapy for breast cancer. Ann Intern Med 1994;120:18–25.
  • Loi S, Milne RL, Friedlander ML, et al Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1686–1691.
  • Meyerhardt JA, Catalano PJ, Haller DG, et al Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003;98:484–495.
  • Jemal A, Siegel R, Ward E, et al Cancer statistics, 2007. CA Cancer J Clin 2007;57:43–66.
  • Charlson ME, Pompei P, Ales KL, et al A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–383.
  • A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993;329:987–994.
  • World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. Tech Rep Series No. 854. Geneva: WHO; 1995.
  • Cheson BD, Horning SJ, Coiffier B, et al Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244.
  • National Cancer Institute. Common toxicity criteria v2.0. Bethesda, MD: NCI; 1998.
  • Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
  • Hosmer DW, Lemeshow S. Applied survival analysis: regression modeling of time to event data. New York: Wiley; 1999.
  • Cox D. Regression models and life tables. J R Stat Soc B 1972;34:187–220.
  • Grambsch PM. Goodness-of-fit and diagnostics for proportional hazards regression models. Cancer Treat Res 1995;75:95–112.
  • Landgren O, Andren H, Nilsson B, et al Risk profile and outcome in Hodgkin's lymphoma: is obesity beneficial? Ann Oncol 2005;16:838–840.
  • Navarro WH, Loberiza FR Jr, Bajorunaite R, et al Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006;12:541–551.
  • Butturini AM, Dorey FJ, Lange BJ, et al Obesity and outcome in pediatric acute lymphoblastic leukemia. J Clin Oncol 2007;25:2063–2069.
  • Lange BJ, Gerbing RB, Feusner J, et al Mortality in overweight and underweight children with acute myeloid leukemia. JAMA 2005;293:203–211.
  • Flegal KM, Graubard BI, Williamson DF, et al Excess deaths associated with underweight, overweight, and obesity. JAMA 2005;293:1861–1867.
  • Heiat A, Vaccarino V, Krumholz HM. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 2001;161:1194–1203.
  • O'Brien JM Jr, Welsh CH, Fish RH, et al Excess body weight is not independently associated with outcome in mechanically ventilated patients with acute lung injury. Ann Intern Med 2004;140:338–345.
  • Rosner GL, Hargis JB, Hollis DR, et al Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541. J Clin Oncol 1996;14:3000–3008.
  • Colleoni M, Li S, Gelber RD, et al Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index. Lancet 2005;366:1108–1110.
  • Griggs JJ, Sabel MS. Obesity and cancer treatment: weighing the evidence. J Clin Oncol 2008;26:4060–4062.
  • Sparreboom A, Wolff AC, Mathijssen RH, et al Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese. J Clin Oncol 2007;25:4707–4713.
  • Simons-Morton DG, Obarzanek E, Cutler JA. Obesity research–limitations of methods, measurements, and medications. JAMA 2006;295:826–828.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.